6-[3,5-bis(trifluoromethyl)anilino]-4-ethyl-N-(oxan-4-ylmethyl)pyridine-3-carboxamide;ethane
C24H29F6N3O2 — CID 142877788
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[3,5-bis(trifluoromethyl)anilino]-4-ethyl-N-(oxan-4-ylmethyl)pyridine-3-carboxamide;ethane
6-[3,5-bis(trifluoromethyl)anilino]-4-ethyl-N-(oxan-4-ylmethyl)pyridine-3-carboxamide;ethane (PubChem CID 142877788) has the molecular formula C24H29F6N3O2 and a molecular weight of 505.50 g/mol. Its IUPAC name is 6-[3,5-bis(trifluoromethyl)anilino]-4-ethyl-N-(oxan-4-ylmethyl)pyridine-3-carboxamide;ethane.
Molecular Properties
| Compound Name | 6-[3,5-bis(trifluoromethyl)anilino]-4-ethyl-N-(oxan-4-ylmethyl)pyridine-3-carboxamide;ethane |
|---|---|
| PubChem CID | 142877788 |
| Molecular Formula | C24H29F6N3O2 |
| Molecular Weight | 505.50 g/mol |
| Exact Mass | 505.22 |
| IUPAC Name | 6-[3,5-bis(trifluoromethyl)anilino]-4-ethyl-N-(oxan-4-ylmethyl)pyridine-3-carboxamide;ethane |
| SMILES | CC.CCc1cc(Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)ncc1C(=O)NCC1CCOCC1 |
| InChI | InChI=1S/C22H23F6N3O2.C2H6/c1-2-14-7-19(29-12-18(14)20(32)30-11-13-3-5-33-6-4-13)31-17-9-15(21(23,24)25)8-16(10-17)22(26,27)28;1-2/h7-10,12-13H,2-6,11H2,1H3,(H,29,31)(H,30,32);1-2H3 |
| InChIKey | UWNGDGZJUHVHAO-UHFFFAOYSA-N |
| XLogP | 6.61 |
| TPSA | 63.25 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 505.50 |
| LogP ≤ 5 | 6.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142877788 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.